R1	Has_qualifier Arg1:T3 Arg2:T2	
R2	Has_qualifier Arg1:T3 Arg2:T1	
R3	Has_index Arg1:T4 Arg2:T5	
R4	Has_temporal Arg1:T3 Arg2:T4	
*	OR T6 T7
R5	Has_context Arg1:T3 Arg2:T6	
R6	AND Arg1:T9 Arg2:T10	
R7	Has_qualifier Arg1:T13 Arg2:T14	
R8	Has_qualifier Arg1:T15 Arg2:T16	
*	OR T17 T18
R9	Has_qualifier Arg1:T17 Arg2:T19	
R10	Has_value Arg1:T22 Arg2:T23	
R11	Has_value Arg1:T24 Arg2:T25	
R12	Has_value Arg1:T26 Arg2:T27	
R13	Has_value Arg1:T29 Arg2:T30	
R14	Has_value Arg1:T31 Arg2:T32	
R15	AND Arg1:T21 Arg2:T22	
R16	AND Arg1:T28 Arg2:T29	
R17	AND Arg1:T17 Arg2:T21	
R18	Has_value Arg1:T37 Arg2:T38	
R19	Has_value Arg1:T39 Arg2:T40	
*	OR T37 T39 T42
R20	Has_value Arg1:T42 Arg2:T43	
R21	Has_value Arg1:T44 Arg2:T45	
*	OR T46 T47 T48
R22	Has_mood Arg1:T50 Arg2:T51	
R23	Has_qualifier Arg1:T53 Arg2:T52	
*	OR T54 T55
R24	Subsumes Arg1:T52 Arg2:T54	
*	OR T59 T58
R25	Has_qualifier Arg1:T59 Arg2:T57	
R26	Has_value Arg1:T61 Arg2:T62	
R27	Has_value Arg1:T63 Arg2:T64	
R28	Has_negation Arg1:T68 Arg2:T67	
R29	Has_value Arg1:T65 Arg2:T66	
R30	AND Arg1:T65 Arg2:T68	
*	OR T61 T65 T63
R31	AND Arg1:T59 Arg2:T61	
*	OR T73 T72
R32	Has_qualifier Arg1:T70 Arg2:T71	
R33	Has_qualifier Arg1:T70 Arg2:T73	
*	OR T75 T76
R34	Has_temporal Arg1:T70 Arg2:T75	
*	OR T79 T80
R35	Has_value Arg1:T79 Arg2:T81	
R36	AND Arg1:T78 Arg2:T79	
R37	AND Arg1:T70 Arg2:T78	
R38	Has_temporal Arg1:T83 Arg2:T84	
R39	AND Arg1:T85 Arg2:T83	
R40	Has_index Arg1:T89 Arg2:T90	
*	OR T87 T88
R41	Has_temporal Arg1:T87 Arg2:T89	
R42	Has_temporal Arg1:T87 Arg2:T86	
*	OR T94 T96 T95
R43	Has_qualifier Arg1:T94 Arg2:T93	
*	OR T87 T92 T94
*	OR T99 T100 T101
R44	Has_qualifier Arg1:T98 Arg2:T99	
R45	Has_multiplier Arg1:T109 Arg2:T108	
R46	Has_temporal Arg1:T109 Arg2:T110	
R47	AND Arg1:T113 Arg2:T114	
R48	Has_temporal Arg1:T113 Arg2:T115	
R49	Has_qualifier Arg1:T113 Arg2:T112	
R50	Has_temporal Arg1:T113 Arg2:T111	
*	OR T103 T113 T107 T106 T105 T104 T109
R51	Subsumes Arg1:T98 Arg2:T103	
R52	Has_index Arg1:T123 Arg2:T124	
*	OR T120 T121 T122
R54	Has_qualifier Arg1:T119 Arg2:T120	
R53	Has_temporal Arg1:T119 Arg2:T123	
R55	Has_qualifier Arg1:T134 Arg2:T135	
*	OR T138 T139
*	OR T141 T144 T142 T143
R56	Subsumes Arg1:T140 Arg2:T141	
R57	Has_negation Arg1:T147 Arg2:T149	
R58	AND Arg1:T146 Arg2:T147	
*	OR T152 T153 T154 T155
R59	AND Arg1:T151 Arg2:T152	
*	OR T161 T164 T162 T163
R61	multi Arg1:T166 Arg2:T159	
R62	Has_qualifier Arg1:T158 Arg2:T166	
R60	Subsumes Arg1:T158 Arg2:T161	
R63	Has_temporal Arg1:T158 Arg2:T160	
*	OR T172 T176 T174 T173 T175
R64	Has_qualifier Arg1:T177 Arg2:T172	
R65	Subsumes Arg1:T171 Arg2:T177	
*	OR T168 T169
R66	Has_temporal Arg1:T170 Arg2:T168	
R67	AND Arg1:T171 Arg2:T170	
R68	Has_negation Arg1:T184 Arg2:T183	
R69	Has_value Arg1:T186 Arg2:T185	
*	OR T188 T187
R70	Has_negation Arg1:T191 Arg2:T192	
R71	Has_qualifier Arg1:T196 Arg2:T195	
R72	Has_qualifier Arg1:T196 Arg2:T194	
R73	Subsumes Arg1:T190 Arg2:T191	
*	OR T190 T199 T197 T198
*	OR T190 T196
R74	AND Arg1:T189 Arg2:T190	
R75	Subsumes Arg1:T184 Arg2:T186	
R76	AND Arg1:T170 Arg2:T184	
*	OR T170 T189
R77	Has_index Arg1:T203 Arg2:T204	
R78	Has_qualifier Arg1:T206 Arg2:T207	
R79	AND Arg1:T205 Arg2:T206	
R80	Has_temporal Arg1:T202 Arg2:T203	
*	OR T202 T205
R82	Has_index Arg1:T211 Arg2:T212	
R81	Has_qualifier Arg1:T208 Arg2:T209	
R83	Has_temporal Arg1:T208 Arg2:T211	
R84	Has_value Arg1:T214 Arg2:T215	
R85	Has_index Arg1:T216 Arg2:T217	
R86	Has_temporal Arg1:T214 Arg2:T216	
*	OR T208 T214
R87	Has_value Arg1:T218 Arg2:T219	
R88	Has_index Arg1:T220 Arg2:T221	
R89	Has_temporal Arg1:T218 Arg2:T220	
*	OR T226 T224 T225 T223
R90	Has_temporal Arg1:T226 Arg2:T222	
R91	Has_temporal Arg1:T228 Arg2:T229	
R92	Has_index Arg1:T229 Arg2:T230	
R93	Has_value Arg1:T232 Arg2:T233	
R94	multi Arg1:T231 Arg2:T232	
R95	Has_qualifier Arg1:T234 Arg2:T235	
*	OR T236 T237
R96	Has_qualifier Arg1:T234 Arg2:T236	
R97	Has_index Arg1:T240 Arg2:T241	
R98	Has_temporal Arg1:T239 Arg2:T240	
R99	Subsumes Arg1:T242 Arg2:T243	
*	OR T242 T244 T245
R100	Has_qualifier Arg1:T247 Arg2:T248	
R101	Has_qualifier Arg1:T250 Arg2:T249	
R102	Has_value Arg1:T251 Arg2:T252	
R103	Has_qualifier Arg1:T254 Arg2:T253	
R104	Subsumes Arg1:T250 Arg2:T251	
*	OR T250 T254 T255 T256
R105	Subsumes Arg1:T247 Arg2:T250	
R106	Has_temporal Arg1:T262 Arg2:T261	
R107	multi Arg1:T261 Arg2:T263	
R108	Has_qualifier Arg1:T264 Arg2:T265	
R110	Has_index Arg1:T268 Arg2:T269	
R111	AND Arg1:T267 Arg2:T266	
R112	Has_index Arg1:T270 Arg2:T271	
R113	Has_index Arg1:T270 Arg2:T272	
R109	Has_temporal Arg1:T267 Arg2:T268	
*	OR T262 T267 T264
R114	Has_value Arg1:T274 Arg2:T275	
R115	Has_qualifier Arg1:T274 Arg2:T276	
R116	Has_qualifier Arg1:T274 Arg2:T278	
R117	Has_qualifier Arg1:T274 Arg2:T277	
R118	Has_multiplier Arg1:T274 Arg2:T279	
R119	Has_qualifier Arg1:T279 Arg2:T280	
R120	Has_qualifier Arg1:T282 Arg2:T283	
R121	Has_temporal Arg1:T282 Arg2:T284	
*	OR T285 T287
R122	Has_temporal Arg1:T285 Arg2:T286	
*	OR T282 T285
R123	Has_mood Arg1:T290 Arg2:T289	
R124	Has_temporal Arg1:T290 Arg2:T291	
R125	Has_index Arg1:T291 Arg2:T292	
R126	AND Arg1:T293 Arg2:T294	
*	OR T290 T294
*	OR T299 T300
*	OR T297 T298
R127	Has_temporal Arg1:T297 Arg2:T299	
R128	Has_value Arg1:T303 Arg2:T304	
R129	Has_value Arg1:T306 Arg2:T305	
R130	Has_qualifier Arg1:T308 Arg2:T307	
R131	Has_index Arg1:T309 Arg2:T310	
R132	Has_temporal Arg1:T306 Arg2:T309	
R133	AND Arg1:T306 Arg2:T308	
R134	AND Arg1:T303 Arg2:T306	
R135	Has_index Arg1:T315 Arg2:T316	
R136	Has_temporal Arg1:T314 Arg2:T315	
R137	Has_qualifier Arg1:T319 Arg2:T318	
R139	Has_value Arg1:T320 Arg2:T321	
R141	AND Arg1:T330 Arg2:T329	
R142	AND Arg1:T330 Arg2:T331	
*	OR T324 T327 T328 T330
R140	Subsumes Arg1:T323 Arg2:T324	
*	OR T320 T322 T323
R143	Has_index Arg1:T333 Arg2:T335	
R144	Has_index Arg1:T334 Arg2:T336	
R145	multi Arg1:T336 Arg2:T337	
R138	Subsumes Arg1:T319 Arg2:T320	
R146	Has_context Arg1:T319 Arg2:T317	
R147	Has_temporal Arg1:T319 Arg2:T333	
R148	Has_temporal Arg1:T319 Arg2:T334	
R149	Has_temporal Arg1:T340 Arg2:T341	
R150	Has_negation Arg1:T344 Arg2:T345	
R151	Has_index Arg1:T346 Arg2:T348	
R153	Has_index Arg1:T347 Arg2:T349	
R154	multi Arg1:T349 Arg2:T350	
*	OR T342 T344
R152	Has_temporal Arg1:T342 Arg2:T346	
R155	Has_context Arg1:T342 Arg2:T343	
R156	Has_temporal Arg1:T356 Arg2:T357	
R157	Has_qualifier Arg1:T356 Arg2:T355	
R158	Has_negation Arg1:T355 Arg2:T354	
R159	Has_index Arg1:T360 Arg2:T361	
R160	Has_qualifier Arg1:T356 Arg2:T364	
R161	Has_qualifier Arg1:T358 Arg2:T363	
R162	Has_temporal Arg1:T358 Arg2:T359	
R163	Has_temporal Arg1:T358 Arg2:T360	
R164	Has_context Arg1:T358 Arg2:T362	
R165	AND Arg1:T21 Arg2:T24	
R166	AND Arg1:T21 Arg2:T26	
R167	AND Arg1:T28 Arg2:T31	
R168	Has_negation Arg1:T148 Arg2:T149	
R169	AND Arg1:T146 Arg2:T148	
R170	Subsumes Arg1:T184 Arg2:T188	
R171	Has_qualifier Arg1:T210 Arg2:T209	
R172	Has_temporal Arg1:T210 Arg2:T211	
*	OR T210 T214
R174	Has_temporal Arg1:T267 Arg2:T270	
*	OR T325 T327 T328 T330
R176	Subsumes Arg1:T323 Arg2:T325	
T1	Qualifier 0 22	Clinically significant
T2	Qualifier 23 26	new
T3	Condition 27 34	illness
T4	Temporal 35 70	within 1 month before randomization
T5	Reference_point 57 70	randomization
T6	Observation 76 146	may affect the participant's ability to fulfill the study requirements
T7	Observation 150 188;76 79	significantly confound the assessments may
T9	Observation 207 221	cannot swallow
T10	Drug 222 246	investigational products
T11	Condition 266 270	T2DM
T12	Condition 280 304	hypoglycemia unawareness
T13	Condition 306 326	Aortic regurgitation
T14	Qualifier 327 342	mild or greater
T15	Condition 344 364	Mitral regurgitation
T16	Qualifier 365 384	moderate or greater
T17	Condition 386 392;403 417	Mitral valve stenosis
T18	Condition 396 417	aortic valve stenosis
T19	Qualifier 418 435	greater than mild
T21	Condition 441 456	aortic stenosis
T22	Measurement 458 461	jet
T23	Value 462 490	>3.0 meters per second [m/s]
T24	Measurement 492 505	mean gradient
T25	Value 506 539	>25 millimeters of mercury [mmHg]
T26	Measurement 545 562	aortic valve area
T27	Value 563 594	<1.5 centimeters squared [cm^2]
T28	Condition 596 611	mitral stenosis
T29	Measurement 613 626	mean gradient
T30	Value 627 634	>5 mmHg
T31	Measurement 639 656	mitral valve area
T32	Value 657 666	<1.5 cm^2
T37	Measurement 669 710	Systolic pulmonary artery pressure (SPAP)
T38	Value 711 719	>40 mmHg
T39	Measurement 728 769	tricuspid regurgitation [TR] jet velocity
T40	Value 770 778	>2.9 m/s
T42	Measurement 1016 1022	RVOTAT
T43	Value 1023 1047	=100 milliseconds (msec)
T41	Non-representable 780 995	In cases where an actual SPAP value is not measurable due to lack of adequate TR jet, the pulmonary flow acceleration time measured at the right ventricular outflow tract (RVOTAT) will be used to assess eligibility.
T44	Measurement 1283 1317	Left ventricular ejection fraction
T45	Value 1318 1322	<45%
T46	Condition 1324 1341	Intracardiac mass
T47	Condition 1343 1348	tumor
T48	Condition 1353 1361	thrombus
T49	Non-representable 1066 1281	suggesting an elevated mean SPAP; eligibility for the those participants with RVOTAT between 100 and 120 msec will be determined based on combined assessment of the TR jet, septal motion, and right ventricular size.
T50	Condition 1375 1399	congenital heart disease
T51	Mood 1363 1374	Evidence of
T52	Qualifier 1401 1423	Clinically significant
T53	Condition 1424 1444	pericardial effusion
T54	Qualifier 1450 1468	moderate or larger
T55	Condition 1477 1499	hemodynamic compromise
T57	Qualifier 1502 1513	Significant
T58	Condition 1523 1538	hepatic disease
T59	Condition 1514 1519;1531 1538	renal disease
T61	Measurement 1557 1573	serum creatinine
T62	Value 1574 1619	greater than 1.5× upper limit of normal (ULN)
T63	Measurement 1621 1640	serum transaminases
T64	Value 1641 1660	greater than 3× ULN
T65	Measurement 1665 1680	total bilirubin
T66	Value 1681 1702	greater than 1.5× ULN
T67	Negation 1706 1716	absence of
T68	Condition 1717 1735	Gilbert's syndrome
T70	Condition 1741 1758	suicidal ideation
T71	Qualifier 1759 1770	with intent
T72	Qualifier 1779 1793	without a plan
T73	Qualifier 1771 1775;1787 1793	with a plan
T75	Temporal 1795 1809;1832 1841	at the time of Screening
T76	Temporal 1813 1841	within 6 months of Screening
T78	Procedure 1902 1982	Suicidal Ideation section of the Columbia-Suicide Severity Rating Scale (C-SSRS)
T79	Measurement 1878 1889	questions 4
T80	Measurement 1878 1887;1893 1894	questions 5
T81	Value 1870 1873	Yes
T83	Condition 1988 2005	suicidal behavior
T84	Temporal 2006 2017	in the past
T85	Procedure 2031 2037	C-SSRS
T86	Temporal 2043 2050	history
T87	Condition 2054 2062	anorexia
T88	Condition 2066 2073	bulimia
T89	Temporal 2074 2105	within 2 years before Screening
T90	Reference_point 2096 2105	Screening
T92	Condition 2107 2147	Attention Deficit Hyperactivity Disorder
T93	Qualifier 2153 2219	Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
T94	Condition 2220 2239	depressive disorder
T95	Condition 2241 2257	bipolar disorder
T96	Condition 2262 2275	schizophrenia
T98	Condition 2283 2299;2335 2346	secondary causes for obesity
T99	Qualifier 2301 2308	genetic
T100	Qualifier 2310 2319	endocrine
T101	Qualifier 2324 2333	metabolic
T103	Condition 2352 2373	Prader-Willi syndrome
T104	Condition 2375 2396	Bardet Biedl syndrome
T105	Condition 2398 2413	Down's Syndrome
T106	Condition 2415 2439	untreated hypothyroidism
T107	Condition 2441 2459	Cushing's syndrome
T108	Multiplier 2461 2466	daily
T109	Drug 2467 2490	systemic corticosteroid
T110	Temporal 2500 2523	for longer than 30 days
T111	Temporal 2525 2532	history
T112	Qualifier 2536 2556	significant exposure
T113	Drug 2560 2575	corticosteroids
T114	Condition 2580 2595	chronic illness
T115	Temporal 2596 2616	during the past year
T116	Non-representable 2618 2650	inhaled steroids will be allowed
T119	Drug 2666 2699	products intended for weight loss
T120	Qualifier 2710 2722	prescription
T121	Qualifier 2730 2752	over-the-counter (OTC)
T122	Qualifier 2764 2770	herbal
T123	Temporal 2784 2815	within 1 month before Screening
T124	Reference_point 2806 2815	Screening
T126	Drug 2817 2856	selective serotonin reuptake inhibitors
T127	Drug 2858 2902	serotonin norepinephrine reuptake inhibitors
T128	Drug 2904 2929	tricyclic antidepressants
T129	Drug 2931 2940	bupropion
T130	Drug 2942 2950	triptans
T131	Drug 2952 2967	St. John's Wort
T132	Drug 2969 2979	tryptophan
T133	Drug 2981 2990	linezolid
T134	Drug 2992 3008	dextromethorphan
T135	Qualifier 3012 3020	any form
T136	Drug 3047 3054	lithium
T137	Drug 3056 3064	tramadol
T138	Drug 3066 3080	antipsychotics
T139	Drug 3090 3110	dopamine antagonists
T140	Drug 3113 3136	antiseizure medications
T141	Drug 3147 3160	valproic acid
T142	Drug 3162 3172	zonisamide
T143	Drug 3174 3184	topiramate
T144	Drug 3190 3201	lamotrigine
T146	Drug 3203 3216	oral steroids
T147	Drug 3230 3246	inhaled steroids
T148	Drug 3218 3225;3238 3246	topical steroids
T149	Negation 3251 3261	acceptable
T151	Drug 3264 3285	stimulant medications
T152	Drug 3291 3298	Ritalin
T153	Drug 3300 3308	Concerta
T154	Drug 3310 3321	Biphetamine
T155	Drug 3327 3336	Dexedrine
T157	Drug 3339 3354	benzodiazepines
T158	Drug 3363 3368	drugs
T159	Condition 3400 3420	cardiac valvulopathy
T160	Temporal 3421 3453	within 6 months before Screening
T161	Drug 3484 3493	pergolide
T162	Drug 3495 3505	ergotamine
T163	Drug 3507 3519	methysergide
T164	Drug 3525 3536	cabergoline
T166	Qualifier 3369 3420	known to increase the risk for cardiac valvulopathy
T168	Temporal 3538 3545	History
T169	Qualifier 3561 3583	clinically significant
T170	Condition 3584 3591	disease
T171	Condition 3597 3607	malignancy
T172	Qualifier 3609 3616	cardiac
T173	Qualifier 3618 3629	respiratory
T174	Qualifier 3631 3647	gastrointestinal
T175	Qualifier 3649 3654	renal
T176	Qualifier 3659 3670	psychiatric
T177	Condition 3671 3678	disease
T183	Negation 3680 3690	other than
T184	Condition 3691 3702	prediabetes
T185	Value 3704 3712	impaired
T186	Measurement 3713 3728	fasting glucose
T187	Condition 3732 3758	impaired glucose tolerance
T188	Condition 3704 3728	impaired fasting glucose
T189	Condition 3761 3776	type 2 diabetes
T190	Drug 3790 3815	oral anti-diabetic agents
T191	Drug 3827 3839	sulfonylurea
T192	Negation 3817 3826	excluding
T194	Qualifier 3844 3855	non-insulin
T195	Qualifier 3856 3866	injectable
T196	Drug 3867 3886	antidiabetic agents
T197	Condition 3888 3911	obstructive sleep apnea
T198	Condition 3913 3925	dyslipidemia
T199	Condition 3931 3963	nonalcoholic fatty liver disease
T202	Drug 3972 3981	Belviq XR
T203	Temporal 3982 4014	within 6 months before Screening
T204	Reference_point 4005 4014	Screening
T205	Condition 4018 4034	hypersensitivity
T206	Drug 4038 4047	Belviq XR
T207	Qualifier 4048 4072	or any of the excipients
T208	Observation 4086 4100	change in diet
T209	Qualifier 4074 4085	Significant
T210	Observation 4086 4095;4104 4130	change in level of physical activity
T211	Temporal 4131 4159	within 1 month before dosing
T212	Reference_point 4153 4159	dosing
T214	Observation 4163 4179	change in weight
T215	Value 4183 4197	more than 5 kg
T216	Temporal 4198 4230	within 3 months before Screening
T217	Reference_point 4221 4230	Screening
T218	Observation 4245 4261;4283 4299	very-low-calorie weight loss diet
T219	Value 4263 4281	<1000 calories/day
T220	Temporal 4300 4332	within 6 months before Screening
T221	Reference_point 4323 4332	Screening
T222	Temporal 4334 4341	History
T223	Condition 4345 4352;4375 4380	alcohol abuse
T224	Condition 4356 4371	drug dependence
T225	Condition 4356 4360;4375 4380	drug abuse
T226	Condition 4345 4352;4361 4371	alcohol dependence
T228	Observation 4382 4403	Recreational drug use
T229	Temporal 4404 4435	within 2 years before Screening
T230	Reference_point 4426 4435	Screening
T231	Condition 4449 4486	human immunodeficiency virus positive
T232	Measurement 4449 4477	human immunodeficiency virus
T233	Value 4478 4486	positive
T234	Condition 4509 4524	viral hepatitis
T235	Qualifier 4502 4508	active
T236	Qualifier 4526 4527	B
T237	Qualifier 4531 4532	C
T239	Condition 4535 4545	Malignancy
T240	Temporal 4546 4577	within 5 years before Screening
T241	Reference_point 4568 4577	Screening
T242	Mood 4579 4612	Unable to attend scheduled visits
T243	Observation 4618 4640	lack of transportation
T244	Observation 4645 4664	lack of a caregiver
T245	Observation 4645 4652;4668 4676	lack of guardian
T246	Observation 4711 4724	Special needs
T247	Observation 4746 4766;4781 4793	unable to comprehend instructions
T248	Qualifier 4767 4780	study-related
T249	Qualifier 4799 4815	mild to profound
T250	Condition 4816 4834	mental retardation
T251	Measurement 4836 4857	intelligence quotient
T252	Value 4858 4861	<70
T253	Qualifier 4864 4882	moderate to severe
T254	Condition 4883 4912	cognitive developmental delay
T255	Condition 4914 4945	pervasive development disorders
T256	Condition 4947 4953	autism
T261	Temporal 4956 4963	Ongoing
T262	Condition 4964 4972	epilepsy
T263	Qualifier 4956 4963	Ongoing
T264	Condition 4982 4998	seizure disorder
T265	Qualifier 4976 4981	other
T266	Drug 5010 5021	medications
T267	Condition 5028 5044	seizure disorder
T268	Temporal 5045 5073	within 6 months of screening
T269	Reference_point 5064 5073	screening
T270	Temporal 5077 5121	any time between screening and randomization
T271	Reference_point 5094 5103	screening
T272	Reference_point 5108 5121	randomization
T274	Measurement 5143 5157	blood pressure
T275	Value 5165 5191	95th percentile or greater
T276	Qualifier 5192 5199	for age
T277	Qualifier 5192 5195;5201 5204	for sex
T278	Qualifier 5192 5195;5210 5216	for height
T279	Multiplier 5220 5239	2 separate readings
T280	Qualifier 5252 5267	2 separate days
T281	Non-representable 5269 5437	Those participants who had uncontrolled hypertension at Screening can be rescreened more than 1 month after initiation or adjustment of antihypertensive therapy 1 time.
T282	Observation 5449 5460;5469 5483	enrolled in clinical study
T283	Qualifier 5461 5468	another
T284	Temporal 5439 5448	Currently
T285	Drug 5500 5520	investigational drug
T286	Temporal 5531 5579	within 30 days before providing informed consent
T287	Device 5524 5530	device
T289	Mood 5581 5588	Planned
T290	Procedure 5589 5606	bariatric surgery
T291	Temporal 5607 5623	during the study
T292	Reference_point 5614 5623	the study
T293	Temporal 5627 5632	prior
T294	Procedure 5633 5662	bariatric surgical procedures
T295	Non-query-able 5664 5862	Not suitable to participate in the study in the opinion of the investigator, including consideration of any existing physical, medical, or mental condition that prevents compliance with the protocol
T296	Person 5864 5870	Female
T297	Observation 5892 5905	breastfeeding
T298	Condition 5909 5917	pregnant
T299	Temporal 5918 5930	at Screening
T300	Temporal 5918 5920;5934 5942	at Baseline
T303	Measurement 5972 6010	beta-human chorionic gonadotropin test
T304	Value 5963 5971	positive
T305	Value 6061 6069	negative
T306	Measurement 6070 6094	screening pregnancy test
T307	Qualifier 6015 6023	separate
T308	Procedure 6024 6043	Baseline assessment
T309	Temporal 6108 6162	more than 72 hours before the first dose of study drug
T310	Reference_point 6134 6162	the first dose of study drug
T314	Condition 6169 6199	unprotected sexual intercourse
T315	Temporal 6200 6233	within 30 days before study entry
T316	Reference_point 6222 6233	study entry
T317	Observation 6242 6254	do not agree
T318	Qualifier 6264 6280	highly effective
T319	Observation 6281 6304	method of contraception
T320	Measurement 6316 6326	abstinence
T321	Value 6310 6315	total
T322	Device 6331 6350	intrauterine device
T323	Observation 6354 6375	double-barrier method
T324	Device 6385 6391	condom
T325	Device 6397 6422	diaphragm with spermicide
T327	Device 6427 6448	contraceptive implant
T328	Drug 6453 6471	oral contraceptive
T329	Procedure 6483 6495	vasectomized
T330	Person 6496 6503	partner
T331	Condition 6519 6530	azoospermia
T333	Temporal 6532 6566	throughout the entire study period
T334	Temporal 6571 6615	for 28 days after study drug discontinuation
T335	Reference_point 6543 6566	the entire study period
T336	Reference_point 6589 6615	study drug discontinuation
T337	Drug 6589 6599	study drug
T340	Condition 6631 6640	abstinent
T341	Temporal 6621 6630	currently
T342	Observation 6667 6688	double-barrier method
T343	Observation 6645 6657	do not agree
T344	Observation 6726 6741	sexual activity
T345	Negation 6713 6720	refrain
T346	Temporal 6742 6765	during the study period
T347	Temporal 6770 6814	for 28 days after study drug discontinuation
T348	Reference_point 6749 6765	the study period
T349	Reference_point 6788 6814	study drug discontinuation
T350	Drug 6788 6798	study drug
T353	Drug 6826 6849	hormonal contraceptives
T354	Negation 6859 6862	not
T355	Qualifier 6868 6879	stable dose
T356	Drug 6892 6914	hormonal contraceptive
T357	Temporal 6923 6957	for at least 4 weeks before dosing
T358	Drug 6995 7008	contraceptive
T359	Temporal 7009 7025	during the study
T360	Temporal 7030 7074	for 28 days after study drug discontinuation
T361	Reference_point 7048 7074	study drug discontinuation
T362	Observation 6966 6978	do not agree
T363	Qualifier 6986 6994	the same
T364	Qualifier 6883 6891	the same
T365	Non-representable 7075 7328	(Note: All female participants will be considered to be of childbearing potential unless they have been sterilized surgically [ie, bilateral tubal ligation, total hysterectomy, or bilateral oophorectomy, all with surgery at least 1 month before dosing])
